Disease recurrence in patients with Crohn's disease after biologic therapy or surgery: a meta-analysis.

Author: KneißlSarah, SchlattmannPeter, StallhoferJohannes, StallmachAndreas

Paper Details 
Original Abstract of the Article :
BACKGROUND: Relapse is a problem in patients with Crohn's disease (CD) after medical therapy (including biologics) and after surgery to treat acute inflammation. It is unclear whether the recurrence rate over time is higher after surgical therapy than after continuous drug treatment. AIM: We sought...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9560971/

データ提供:米国国立医学図書館(NLM)

Relapse in Crohn's Disease: Comparing Biologic Therapy and Surgery

Crohn's disease, a chronic inflammatory bowel disease, can be a challenging condition to manage. This study delves into the complex question of relapse rates after treatment with biologic therapy or surgery. The researchers conducted a comprehensive meta-analysis to compare the effectiveness of these two approaches. The study sheds light on the long-term outcomes of both treatment options, offering valuable insights for healthcare providers and patients navigating this challenging condition.

Surgery Outperforms Biologic Therapy in Long-Term Outcomes

The researchers found that the need for re-interventions (surgery, biologics, or both) increased over time for patients with Crohn's disease. Interestingly, the recurrence rates after ileocecal resection (surgical removal of the ileum and cecum) were lower than those seen with continuous biologic therapy. These findings suggest that surgical resection might be a more effective treatment option for patients with Crohn's disease, especially those with limited disease, as it may offer longer-lasting relief from symptoms. However, it's important to consider the risks and benefits of both treatment options on an individual basis.

Informed Decision-Making for Crohn's Disease Management

This study provides crucial information for patients with Crohn's disease and their healthcare providers. The findings highlight the need for careful consideration of treatment options, weighing the potential benefits and risks of both biologic therapy and surgery. Patients should discuss their individual circumstances with their doctor to determine the most appropriate course of treatment. This is a key step in managing this complex disease and achieving optimal outcomes.

Dr. Camel's Conclusion

This study reminds us that the journey with Crohn's disease can be a long and winding one, full of unexpected turns. Understanding the long-term implications of treatment options is crucial for making informed decisions and navigating this challenging condition. It's like navigating a desert with shifting sands, where the right path might be different for each traveler. Ultimately, the goal is to find the treatment strategy that best fits the individual needs and priorities of each patient.

Date :
  1. Date Completed 2022-10-17
  2. Date Revised 2022-11-06
Further Info :

Pubmed ID

36149447

DOI: Digital Object Identifier

PMC9560971

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.